Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
XORTX Therapeutics Inc. (XRTX) had Return on Tangible Equity of -105.07% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-3.31M |
|
-- |
|
-- |
|
$4.12M |
|
$-4.12M |
|
$0.81M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-4.12M |
|
$-4.00M |
|
2.88M |
|
2.88M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$2.68M |
|
$0.03M |
|
$1.42M |
|
$4.09M |
|
$0.76M |
|
-- |
|
-- |
|
$0.76M |
|
$3.34M |
|
$3.15M |
|
$3.34M |
|
3.48M |
|
| Cash Flow Statement Financials | |
$-3.68M |
|
$-0.04M |
|
$2.78M |
|
$3.45M |
|
$2.47M |
|
$-0.97M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.53 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-99.31% |
|
|
Return on Tangible Equity |
-105.07% |
-80.92% |
|
-99.30% |
|
$0.96 |
|
$-1.28 |
|
$-1.28 |
|